Advertisement
Research Article| Volume 9, ISSUE 1, P153-168, March 1989

The Status of Hypertriglyceridemia as a Risk Factor for Coronary Heart Disease

  • Author Footnotes
    * Fellow, Divisions of General Internal Medicine and Clinical Epidemiology
    Andrew L. Avins
    Correspondence
    Corresponding author: Clinical Epidemiology Program, University of California San Francisco, Box 0886, San Francisco, California 94143.
    Footnotes
    * Fellow, Divisions of General Internal Medicine and Clinical Epidemiology
    Affiliations
    From the Departments of Medicine and Clinical Epidemiology, University of California, San Francisco, and the Division of General Internal Medicine, San Francisco General Hospital, San Francisco, California
    Search for articles by this author
  • Author Footnotes
    † Associate Professor of Medicine, Chief, Division of General Internal Medicine
    Richard J. Haber
    Footnotes
    † Associate Professor of Medicine, Chief, Division of General Internal Medicine
    Affiliations
    From the Departments of Medicine and Clinical Epidemiology, University of California, San Francisco, and the Division of General Internal Medicine, San Francisco General Hospital, San Francisco, California
    Search for articles by this author
  • Author Footnotes
    ‡ Professor of Epidemiology and Medicine, Vice-Chairman, Department of Epidemiology and International Health
    Stephen B. Hulley
    Footnotes
    ‡ Professor of Epidemiology and Medicine, Vice-Chairman, Department of Epidemiology and International Health
    Affiliations
    From the Departments of Medicine and Clinical Epidemiology, University of California, San Francisco, and the Division of General Internal Medicine, San Francisco General Hospital, San Francisco, California
    Search for articles by this author
  • Author Footnotes
    * Fellow, Divisions of General Internal Medicine and Clinical Epidemiology
    † Associate Professor of Medicine, Chief, Division of General Internal Medicine
    ‡ Professor of Epidemiology and Medicine, Vice-Chairman, Department of Epidemiology and International Health
DOI:https://doi.org/10.1016/S0272-2712(18)30647-4
The Status of Hypertriglyceridemia as a Risk Factor for Coronary Heart Disease
Previous ArticleApoprotein Measurements and Their Clinical Application
Next ArticleTriglyceride Measurement and Its Relationship to Heart Disease
      This paper is only available as a PDF. To read, Please Download here.
      The three-decade long controversy surrounding the status of triglycerides as an independent risk factor for coronary heart disease is presented. The studies that reported an association and the clinical trials of cholesterol-lowering medications are examined. Because of the inconsistency between the observational findings and the consistently negative clinical trial findings, treatment of isolated hypertriglyceridemia cannot be recommended at present.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Aberg H.
        • Lithell H.
        • Selinus I.
        Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris.
        Atherosclerosis. 1985; 54: 89
        • Barrett-Connor E.
        • Khaw K.
        Borderline fasting hypertriglyceridemia: Absence of excess risk of all-cause and cardiovascular disease mortality in healthy men without hypercholesterolemia.
        Prev Med. 1987; 16: 1
        • Blankenhorn D.H.
        • Nessim S.A.
        • Johnson R.L.
        • et al.
        Beneficial effects of combined colesti-pol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
        JAMA. 1987; 257: 3233
        • Brunzell J.D.
        • Bierman E.L.
        Chylomicronemia syndrome: Interactions of genetic and acquired hypertriglyceridemia.
        Med Clin North Am. 1982; 66: 455
        • Cambien F.
        • Jacqueson A.
        • Richard J.L.
        • et al.
        Is the level of serum triglyceride a significant predictor of coronary death in “normocholesterolemic” subjects?.
        Am J Epidemiol. 1986; 124: 624
        • Canner P.L.
        • Berge K.G.
        • Wenger N.K.
        • et al.
        Fifteen year mortality in coronary drug project patients: Long-term benefit with niacin.
        J Am Coll Cardiol. 1986; 8: 1245
        • Carlson L.A.
        • Bottiger L.E.
        Risk factors for ischaemic heart disease in men and women.
        Acta Med Scand. 1985; 218: 207
        • Carlson L.A.
        • Bottiger L.E.
        Serum triglycerides, to be or not to be a risk factor for ischaemic heart disease?.
        Atherosclerosis. 1981; 39: 287
        • Copeland K.T.
        • Checkoway H.
        • McMichael A.J.
        • et al.
        Bias due to misclassification in the sestimation of relative risk.
        Am J Epidemiol. 1977; 105: 488
        • Criqui M.H.
        • Heiss G.
        • Cohn R.
        • et al.
        Triglycerides and coronary heart disease mortality. The Lipid Research Clinics Follow-up study.
        CVD Epidemiology Newsletter (abstract). 1987; 41: 13
        • Eisenberg S.
        Lipoprotein abnormalities in HTG: Significance in atherosclerosis.
        Am Heart J. 1987; 113: 555
      12. Expert Panel: Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults.
        Arch Intern Med. 1988; 148: 36
        • Fager G.
        • Wiklund O.
        • Olofsson S.
        • et al.
        Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.
        Arteriosclerosis. 1981; 1: 273
        • Freedman D.S.
        • Gruchow H.W.
        • Anderson A.J.
        • et al.
        Relation of triglyceride levels to coronary artery disease: The Milwaukee cardiovascular data registry.
        Am J Epidemiol. 1988; 127: 1118
        • Freiman J.A.
        • Chalmers T.C.
        • Smith H.
        • et al.
        The importance of the beta, or type II, error and sample size in the design and interpretation of the randomized controlled trial: Survey of 71 “negative” trials.
        N Engl J Med. 1978; 299: 690
        • Frick M.H.
        • Elo O.
        • Haapa K.
        • et al.
        Helsinki heart study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia.
        N Engl J Med. 1987; 317: 1237
        • Friedwald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-den-sity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499
        • Glynn R.J.
        • Rosner B.
        • Silbert J.E.
        Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men.
        Circulation. 1982; 66: 724
        • Goldstein J.L.
        • Schrott H.G.
        • Hazzard W.R.
        • et al.
        Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.
        J Clin Invest. 1973; 52: 1544
        • Grundy S.M.
        HTG: Mechanisms, clinical significance, and treatment.
        Med Clin North Am. 1982; 66: 521
        • Hamsten A.
        • Walldius G.
        • Dahlen G.
        • et al.
        Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction.
        Atherosclerosis. 1986; 59: 223
        • Hey den S
        • Heiss G.
        • Hames C.G.
        • et al.
        Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia.
        J Chron Dis. 1980; 33: 275
        • Hoeg J.M.
        • Gregg R.E.
        • Brewer H.B.
        An approach to the management of hyperlipoproteinemia.
        JAMA. 1986; 255: 512
        • Hollister L.E.
        • Beckman W.G.
        • Baker M.
        Comparative variability of serum cholesterol and serum triglycerides.
        Am J Med Sci. 1964; 248: 329
        • Holmes D.R.
        • Elveback L.R.
        • Frye R.L.
        • et al.
        Association of risk factor variables andcoronary artery disease documented with angiography.
        Circulation. 1981; 63: 293
        • Hopkins P.N.
        • Williams R.R.
        Identification and relative weight of cardiovascular riskfactors.
        Cardiol Clin. 1986; 4: 3
        • Hulley S.B.
        • Rosenman R.H.
        • Bawol R.D.
        • et al.
        Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease.
        N Engl J Med. 1980; 302: 1383
        • Jacobs D.R.
        • Barrett-Connor E.
        Retest reliability of plasma cholesterol and triglyceride.
        Am J Epidemiol. 1982; 116: 878
        • Kameda K.
        • Matsuzawa Y.
        • Kubo M.
        • et al.
        Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.
        Atherosclerosis. 1984; 51: 241
        • Kaukola S.
        • Manninen V.
        • Halonen P.I.
        Serum lipids with special reference to HDL cholesterol and triglycerides in young male survivors of acute myocardial infarction.
        Acta Med Scand. 1980; 208: 41
        • Kelsey J.L.
        • Thompson W.D.
        • Evans A.S.
        Methods in Observational Epidemiology. Oxford University Press, New York1986: 285
        • Kleinbaum D.G.
        • Kupper L.L.
        • Morganstern H.
        Epidemiologic Research: Principles and Quantitative Methods. Lifelong Learning Publications, Belmont, California1982: 78
        • Kukita H.
        • Imamura Y.
        • Hamada M.
        • et al.
        Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives.
        Atherosclerosis. 1982; 42: 21
        • Lapidus L.
        • Bengtsson C.
        • Lindquist O.
        • et al.
        Triglycerides—main lipid risk factor for cardiovascular disease in women?.
        Acta Med Scand. 1985; 217: 481
        • Lavie C.J.
        • Gau G.T.
        • Squires R.W.
        • et al.
        Management of lipids in primary and secondary prevention of cardiovascular disease.
        Mayo Clin Proc. 1988; 63: 605
        • Levy R.I.
        • Brensike J.F.
        • Epstein S.E.
        • et al.
        The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: Results of the NHLBI Type II coronary intervention study.
        Circulation. 1984; 69: 325
        • Lipid Research Clinics Program
        The lipid research clinics coronary primary prevention trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
        JAMA. 1984; 251: 365
        • Mannienen V.
        • Elo O.
        • Frick H.
        • et al.
        Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki heart study.
        JAMA. 1988; 260: 641
        • Miller N.E.
        • Hammett F.
        • Saltissi S.
        • et al.
        Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.
        Br Med J. 1981; 282: 1741
        • Motulsky A.G.
        Current concepts in genetics: The genetic hyperlipidemias.
        N Engl J Med. 1976; 294: 823
        • National Heart, Lung, and Blood Institute Consensus Development Panel
        Treatment of hypertriglyceridemia.
        JAMA. 1984; 251: 1196
        • Nestel P.J.
        Is serum triglyceride an independent predictor of coronary artery disease?.
        Pract Cardiol. 1987; 13: 96
        • Perry R.S.
        Contemporary recommendations for evaluating and treating hyperlipidemia.
        Clin Pharm. 1986; 5: 113
        • Petersson B.
        • Trell E.
        • Bertil H.
        Premature death and associated risk factors in urban middle-aged men.
        Am J Med. 1984; 77: 418
        • Philippi T.
        • Barrett-Connor E.
        Fasting plasma glucose, uric acid, and triglycerides as predictors of the ratio of total cholesterol to HDL-C.
        Am J Clin Pathol. 1984; 82: 329
        • Reardon M.F.
        • Nestel P.J.
        • Craig I.H.
        • et al.
        Lipoprotein predictors of the severity of coronary artery disease in men and women.
        Circulation. 1985; 71: 881
        • Rhoads G.G.
        • Feinleib M.
        Serum triglyceride and risk of coronary heart disease, stroke and total mortality in Japanese-American men.
        Arteriosclerosis. 1983; 3: 316
        • Rosenhamer G.
        • Carlson L.A.
        Effect of combined clofibrate-nicotinic acid treatment in ischemic heart disease.
        Atherosclerosis. 1980; 37: 129
        • Salonen J.T.
        • Puska P.
        Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population.
        Int J Epidemiol. 1983; 12: 26
        • Scheidt S.
        Lipid regulation: A clinician′s view of patient management.
        Am Heart J. 1986; 112: 437
        • Shaper A.G.
        • Pocock S.J.
        • Walker M.
        • et al.
        Risk factors for ischaemic heart disease: The prospective phase of the British regional heart study.
        J Epidemiol Comm Health. 1985; 39: 197
        • Simons L.A.
        Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries.
        Am J Cardiol. 1986; 57: 5G
        • Thind I.S.
        • Sandhu R.S.
        Signification of high density and total cholesterol and triglycerides in acute myocardial infarction—a case-control study.
        Clin Biochem. 1981; 14: 57
        • Tibblin G.
        • Cramer K.
        Serum lipids during the course of an acute myocardial infarction and one year afterwards.
        Acta Med Scand. 1963; 174: 451
        • Wallace R.B.
        • Anderson R.A.
        Blood lipids, lipid-related measures, and the risk of atherosclerotic cardiovascular disease.
        Epidem Rev. 1987; 9: 95
        • Warnick G.R.
        • Albers J.J.
        Physiological and analytical variation in cholesterol and triglycerides.
        Lipids. 1975; 11: 203
        • Wieland H.
        • Seidel D.
        • Wiegand V.
        • et al.
        Serum lipoproteins and coronary artery disease.
        Atherosclerosis. 1980; 36: 269
        • Witztum J.
        • Dillingham M.A.
        • Giese W.
        • et al.
        Normalization of triglycerides in type IV hyperlipoproteinemia fails to correct low levels of high-density lipoprotein cholesterol.
        N Engl J Med. 1980; 303: 907
        • Zampogna A.
        • Luria M.H.
        • Manubens S.J.
        • et al.
        Relationship between lipids and occlusive coronary artery disease.
        Arch Intern Med. 1980; 140: 1067

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30647-4

      Copyright

      © 1989 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX